alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Filed: October 18, 1996

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 96-7159

(CR-92-142, CA-96-217-R)

United States of America,

Plaintiff - Appellee,

versus

Ronson O'Shea Barnwell,

Defendant - Appellant.

ORDER

The Court amends its opinion filed October 15, 1996, as

follows:

On the cover sheet, section 4 -- the decision line is

completed to show the decided date -- "Decided: October 15, 1996."

For the Court - By Direction

/s/ Patricia S. Connor

Clerk
2

UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 96-7159

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

RONSON O'SHEA BARNWELL,

Defendant - Appellant.

Appeal from the United States District Court for the Western District of Virginia, at Roanoke. Jackson L. Kiser, Chief District

Judge. (CR-92-142, CA-96-217-R)

Submitted: October 3, 1996 Decided: October 15, 1996

Before ERVIN, LUTTIG, and MICHAEL, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Ronson O'Shea Barnwell, Appellant Pro Se. Ruth Elizabeth

Plagenhoef, Assistant United States Attorney, Roanoke, Virginia,

for Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
3

PER CURIAM:

Appellant appeals from the district court's order denying

Appellant's motion for reconsideration. We have reviewed the record

and the district court's opinion and find no reversible error. See

Bailey v. United States, ___ U.S. ___, 64 U.S.L.W. 4039 (U.S. Dec.

6, 1995) (No. 94-7448); United States Sentencing Commission, Guidelines Manual, § 2D1.1(b)(1). Accordingly, we deny a certificate of

appealability and dismiss. We dispense with oral argument because

the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional

process.

DISMISSED
****

----
Exhibit 31.1
CERTIFICATIONS
I, D. Gary McRae, certify that:
1. I have reviewed this quarterly report on Form 10-Q of McRae Industries,Inc.; 2. Based on my knowledge, this report does not contain any untrue statementof a material fact or omit to state a material fact necessary to make thestatements made, in light of the circumstances under which such statementswere made, not misleading with respect to the period covered by thisreport; 3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all materialrespects the financial condition, results of operations and cash flows ofthe registrant as of, and for, the periods presented in this quarterlyreport; 4. The registrant’s other certifying officers and I are responsible forestablishing and maintaining disclosure controls and procedures (asdefined in Exchange Act Rules 13a-14 and 15d-14) for the registrant andhave:
a) Designed such disclosure controls and procedures, or causedsuch disclosure controls and procedures to be designed under oursupervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made knownto us by others within those entities, particularly during theperiod in which this report is being prepared; b) Evaluated the effectiveness of the registrant’s disclosurecontrols and procedures and presented in this report our conclusionsabout the effectiveness of the disclosure controls and procedures,as of the end of the period covered by this report based on suchevaluation; and c) Disclosed in this report any change in the registrant’sinternal control over financial reporting that occurred during theregistrant’s most recent fiscal quarter (the registrant’s fourthfiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting;
5. The registrant’s other certifying officers and I have disclosed, based onour most recent evaluation of internal control over financial reporting,to the registrant’s auditors and the audit committee of the registrant’sboard of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in thedesign or operation of internal control over financial reportingwhich are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financialinformation; and b) Any fraud, whether or not material, that involves managementor other employees who have a significant role in the registrant’sinternal control over financial reporting.
Date: March 16, 2004
/s/D. Gary McRaeD. Gary McRaePresident and CEO
19
Market SpecificReports

These overviews provide valuable information about some of theUnited States' most important export markets. Market SpecificReports Detailed information on marketing certain products inspecific countries are contained in these reports.

To order reports that are not available from the FAS web,contact the Trade Assistance and Promotion Office (TAPO) tel.(202) 720-7420 fax (202) 205-9728 or email [email protected]. 

| Product Briefs                  | Country Sector        Reports     |
|---------------------------------|-----------------------------------|
| General Market        Overviews | Country Import        Regulations |

Other reports from FAS Overseas offices can be found in the Attache Reportssearch engine.

|                                         |
|----------------------------------------------|
| *Last modified: Wednesday, January 20, 1999* |
§ 510.205 Beneficiary inclusion criteria. ( a ) Episodes tested in the CJR model include only those in which care is furnished to beneficiaries who meet all of the following criteria upon admission to the anchor hospitalization: ( 1 ) Are enrolled in Medicare Parts A and Part B.
( 2 ) Eligibility for Medicare is not on the basis of end stage renal disease, as described in § 406.13 of this chapter.
( 3 ) Are not enrolled in any managed care plan (for example, Medicare Advantage, health care prepayment plans, or cost-based health maintenance organizations).
( 4 ) Are not covered under a United Mine Workers of America health care plan.
( 5 ) Have Medicare as their primary payer.
( 6 ) For episodes beginning on or after July 1, 2017, are not prospectively assigned to— ( i ) An ACO in the Next Generation ACO model;
( ii ) An ACO in a track of the Comprehensive ESRD Care Model incorporating downside risk for financial losses; or
( iii ) A Shared Savings Program ACO in the ENHANCED track (formerly Track 3).
( b ) If at any time during the episode a beneficiary no longer meets all of the criteria in this section, the episode is canceled in accordance with § 510.210(b).
[80 FR 73540, Nov. 24, 2015, as amended at 82 FR 613, Jan. 3, 2017; 86 FR 23571, May 3, 2021]
<TABLE>

                      IPALCO ENTERPRISES, INC.

          Exhibit 11.1 - Computation of Per Share Earnings

                For the Quarter Ended June 30, 2000

<CAPTION>



QUARTER ENDED JUNE 30, 2000:
                                                                    Basic               Diluted
                                                                 --------------       -------------

Weighted average number of shares
<S>                                                              <C>                  <C>
        Average common shares outstanding at June 30, 2000         85,713,007          85,713,007
        Dilutive effect for stock options at June 30, 2000                -               887,807
                                                                 --------------       -------------

        Adjusted weighted average shares at June 30, 2000          85,713,007          86,600,814
                                                                 ==============       =============


Net income to be used to compute
   diluted earnings per share                                               (Dollars in
                                                                             thousands)
       Net income                                                     $28,980             $28,980
                                                                 ==============       =============

Earnings Per Share                                                       $.34                $.33
                                                                 ==============       =============





                For the Six Months Ended June 30, 2000



SIX MONTHS ENDED JUNE 30, 2000:
                                                                    Basic               Diluted
                                                                 --------------       -------------

Weighted average number of shares
        Average common shares outstanding at June 30, 2000         85,707,663          85,707,663
        Dilutive effect for stock options at June 30, 2000                -               722,660
                                                                 --------------       -------------

        Adjusted weighted average shares at June 30, 2000          85,707,663          86,430,323
                                                                 ==============       =============


Net income to be used to compute
   diluted earnings per share                                               (Dollars in
                                                                             thousands)
       Net income                                                    $121,307            $121,307
                                                                 ==============       =============

Earnings Per Share                                                      $1.42               $1.40
                                                                 ==============       =============




</TABLE>
Steven Greene

Attorney at Law

P.O. Box 232

Anahuac, Texas 77514

(409) 267-6290

February 19, 2024

Ruben Morin, Clerk of the Court

Fifth Court of Appeals

George L. Allen, Sr. Courts Bldg.

600 Commerce Street, Suite 200

Dallas, Texas 75202-4658

RE: Cause No. 05-24-00075-CR & 05-24-00076-CR & 05-24-00077-CR; Michael 

Munoz v. The State of Texas 

Please note that part of the Reporter’s has NOT been filed, the part that is due 

from court reporters Carol Castillo and Maria Gallegos, which includes the record 

of the actual trial in this case. I can’t begin to work on my brief until I receive the 

remainder of the record, so I would request that the Court delete March 17, 2024, 

as the due date for my brief.

Sincerely,

/s/ Steven Greene

Steven Greene 

cc: Joe Gonzales, daappealsdivision@bexar.org

ACCEPTED

05-24-00075-CR

FIFTH COURT OF APPEALS

DALLAS, TEXAS

2/19/2024 9:25 AM

RUBEN MORIN

CLERK

 FILED IN 5th COURT OF APPEALS DALLAS, TEXAS 2/19/2024 9:25:37 AM Ruben Morin Clerk
§ 493.1363 Standard: PPM testing personnel qualifications. Each individual performing PPM procedures must— ( a ) Possess a current license issued by the State in which the laboratory is located if the licensing is required; and
( b ) Meet one of the following requirements: ( 1 ) Be a physician, as defined in § 493.2.
( 2 ) Be a midlevel practitioner, as defined in § 493.2, under the supervision of a physician or in independent practice if authorized by the State in which the laboratory is located.
( 3 ) Be a dentist as defined in § 493.2 of this part.
###### Editorial Note on Part 1

#### Editorial Notes:

1. In Patent and Trademark Office publications and usage the part number is omitted from the numbers of §§ 1.1 to 1.352 and the numbers to the right of the decimal point correspond with the respective rule numbers.

2. For nomenclature changes to part 1, see 68 FR 14335, Mar. 25, 2003; 87 FR 68904, Nov. 17, 2022.

#### § 1.70 [Reserved]

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.
#### Ex parte State of Alabama ex rel. Attorney General. (Re: Wade SEXTON v. STATE of Alabama).

80-167.

Supreme Court of Alabama.

Jan. 30, 1981.

*1242ALMON, Justice.

WRIT DENIED — NO OPINION.

TORBERT, C. J., and FAULKNER, EM-BRY and ADAMS, JJ., concur.
§ 486.505 Definitions. As used in §§ 486.520 and 486.525: *Applicable provider* means a physician, a nurse practitioner, and a physician assistant.
*Home* means a place of residence used as the home of an individual, including an institution that is used as a home. An institution that is used as a home may not be a hospital, CAH, or SNF as defined in section 1861(e)(1), 1861(mm)(1), or 1819(a)(1) of the Act, respectively.
*Home infusion drug* means a parental drug or biological administered intravenously, or subcutaneously for an administration period of 15 minutes or more, in the home of an individual through a pump that is an item of durable medical equipment. The term does not include insulin pump systems or a self-administered drug or biological on a self-administered drug exclusion list.
*Infusion drug administration calendar day* means the day on which home infusion therapy services are furnished by skilled professionals in the individual's home on the day of infusion drug administration. The skilled services provided on such day must be so inherently complex that they can only be safely and effectively performed by, or under the supervision of, professional or technical personnel.
*Qualified home infusion therapy supplier* means a supplier of home infusion therapy that meets the all of the following criteria which are set forth at section 1861(iii)(3)(D)(i) of the Act: ( 1 ) Furnishes infusion therapy to individuals with acute or chronic conditions requiring administration of home infusion drugs.
( 2 ) Ensures the safe and effective provision and administration of home infusion therapy on a 7-day-a-week, 24-hour-a-day basis.
( 3 ) Is accredited by an organization designated by the Secretary in accordance with section 1834(u)(5) of the Act.
( 4 ) Meets such other requirements as the Secretary determines appropriate.
[83 FR 56630, Nov. 13, 2018, as amended at 84 FR 60646, Nov. 8, 2019]
Editorial Note on Part 457
Editorial Note: Nomenclature changes to part 457 appear at 75 FR 48852, Aug. 11, 2010 and 77 FR 17213, 2013.

§ 457.740 State expenditures and statistical reports. ( a ) *Required quarterly reports.* A State must submit reports to CMS that contain quarterly program expenditures and statistical data no later than 30 days after the end of each quarter of the Federal fiscal year. A State must collect required data beginning on the date of implementation of the approved State plan. Territories are exempt from the definition of “State” for purposes of the required quarterly reporting under this section. The quarterly reports must include data on— ( 1 ) Program expenditures;
( 2 ) The number of children enrolled in the title XIX Medicaid program, the separate child health program, and the Medicaid expansion program, as applicable, as of the last day of each quarter of the Federal fiscal year; and
( 3 ) The number of children under 19 years of age who are enrolled in the title XIX Medicaid program, the separate child health program, and in the Medicaid expansion program, as appropriate, by the following categories: ( i ) Age (under 1 year of age, 1 through 5 years of age, 6 through 12 years of age, and 13 through 18 years of age).
( ii ) Gender, race, and ethnicity.
( iii ) Service delivery system (managed care, fee-for-service, and primary care case management).
( iv ) Household income as a percentage of the Federal poverty level as described in paragraph (b) of this section.
( b ) *Reportable household income categories.* ( 1 ) A State that does not impose cost sharing or a State that imposes cost sharing based on a fixed percentage of income must report by two household income categories: ( i ) At or below 150 percent of FPL.
( ii ) Over 150 percent of FPL.
( 2 ) A State that imposes a different level or percentage of cost sharing at different poverty levels must report by poverty level categories that match the poverty level categories used for purposes of cost sharing.
( c ) *Required unduplicated counts.* Thirty days after the end of the Federal fiscal year, the State must submit an unduplicated count for the Federal fiscal year of children who were enrolled in the Medicaid program, the separate child health program, and the Medicaid expansion program, as appropriate, by age, gender, race, ethnicity, service delivery system, and poverty level categories described in paragraphs (a) and (b) of this section.
- Office Home
- About Us
- Members
- Remarks and Releases

HomeThe Global Coalition To Defeat ISIS...Remarks and Releases – The Global Coalition To Defeat ISIS

# 						Remarks and Releases – The Global Coalition To Defeat ISIS					

46 items
Clear All Filters

## View collection by:

Select a Year202420232022202120202019

Select a MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember

Select a SpeakerAntony J. BlinkenIan J. McCaryIan MossMatthew MillerNed PriceTimothy Alan BettsVedant Patel

Select a LocationAfghanistanBelgiumIraqItalyKyrgyzstanLibyaMoroccoMozambiqueNigerNorwayOmanRussiaSaudi ArabiaSomaliaSyriaUkraineUnited Arab EmiratesUnited KingdomUzbekistanYemen

Select a Release TypeFact SheetMedia NoteOther ReleasePress StatementRemarksSpecial Briefing

Select a Bureau/OfficeBureau of African AffairsBureau of CounterterrorismBureau of Democracy, Human Rights, and LaborBureau of European and Eurasian AffairsBureau of Near Eastern AffairsBureau of South and Central Asian AffairsDeputy Secretary of StateOffice of the SpokespersonThe Global Coalition To Defeat ISISThe Secretary of StateUnder Secretary for Political Affairs

          -    Remarks  		Resolving the Detainee Dilemma: What Next for the Men, Women & Children of the Islamic State	  Ian MossJune 16, 2022International Center for the Study of RadicalisationKing’s College London 
          -    Media Note  		Joint Communiqué by Ministers of the Global Coalition to Defeat ISIS	  May 11, 2022 
          -    Media Note  		Under Secretary Nuland’s Travel to Morocco	  May 10, 2022 
          -    Media Note  		Joint Communiqué on the Morocco-U.S. Strategic Dialogue on Regional Political Issues	  March 8, 2022 
          -    Press Statement  		An Important Milestone in the Campaign Against ISIS	  Antony J. BlinkenFebruary 3, 2022 
          -    Press Statement  		ISIS Attacks in Syria	  Ned PriceJanuary 22, 2022 
          -    Media Note  		Political Directors Small Group Meeting of the Global Coalition to Defeat Daesh/ISIS	  December 3, 2021 
          -    Press Statement  		Taking Action Against ISIS-K	  Antony J. BlinkenNovember 22, 2021 
          -    Media Note  		Acting Coordinator for Counterterrorism John T. Godfrey Travel to Oman, UAE, London	  September 24, 2021 
          -    Media Note  		Readout of the Political Directors Small Group Meeting of the Global Coalition to Defeat Daesh/ISIS	  September 9, 2021 

previous page12345next page

Back to Top
###### Editorial Note on Part 212

#### Editorial Note:

Nomenclature changes to part 212 appear at 82 FR 9366, Feb. 6, 2017.

#### § 212.6 Recordation of transfers and other documents.

The conditions prescribed in § 201.4 of this chapter for recordation of transfers of copyright ownership and other documents pertaining to copyright are applicable to the recordation of documents pertaining to the protection of vessel designs under 17 U.S.C. chapter 13.

[64 FR 36578, July 7, 1999, as amended at 82 FR 9366, Feb. 6, 2017]
<PAGE>   1
                        DEP CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED CONDENSED STATEMENTS OF
                        COMPUTATION OF EARNINGS PER SHARE
                                   (UNAUDITED)


<TABLE>
<CAPTION>
                                                                Three Months Ended                  Nine Months Ended
                                                                     April 30,                            April 30,
                                                           -----------------------------        -----------------------------
                                                              1998              1997               1998              1997
                                                           -----------       -----------        -----------       -----------
<S>                                                        <C>               <C>                <C>               <C>         
Net income (loss) ..................................       $   681,000       $  (613,000)       $ 1,961,000       $(2,612,000)
                                                           ===========       ===========        ===========       ===========

Shares:
Weighted average shares outstanding - basic                  6,876,140         6,876,140          6,876,140         6,643,842

Effect of dilutive stock options ...................           162,231            18,670             80,493            49,656
                                                           -----------       -----------        -----------       -----------

Weighted average shares outstanding - diluted ......         7,038,371         6,894,810          6,956,633         6,693,498
                                                           ===========       ===========        ===========       ===========

Earnings (loss) per common share:
Basic ..............................................       $      0.10       $     (0.09)       $      0.28       $     (0.39)
                                                           ===========       ===========        ===========       ===========

Diluted ............................................       $      0.10       $     (0.09)       $      0.28       $     (0.39)
                                                           ===========       ===========        ===========       ===========
</TABLE>


                                   Exhibit 11